Hazard Arh Regional Medical Center

Hazard, Kentucky 41702

0 studies enrolling now · 3 studies all time

What they study most

Chronic Phase Chronic Myeloid Leukemia, Lung Cancer

Studies at this site

• Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States — Completed
• Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program — Completed
• Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning — Completed